Glaukos Return on Investment 2014-2022 | GKOS

Current and historical return on investment (ROI) values for Glaukos (GKOS) over the last 10 years.
Glaukos ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2022-09-30 $-0.07B $0.90B -7.23%
2022-06-30 $-0.03B $0.92B -3.62%
2022-03-31 $-0.01B $0.95B -1.26%
2021-12-31 $-0.03B $0.94B -4.12%
2021-09-30 $-0.03B $0.95B -3.27%
2021-06-30 $-0.05B $0.66B -6.25%
2021-03-31 $-0.08B $0.65B -9.69%
2020-12-31 $-0.12B $0.92B -14.32%
2020-09-30 $-0.14B $0.91B -17.48%
2020-06-30 $-0.14B $0.91B -21.85%
2020-03-31 $-0.10B $0.70B -20.74%
2019-12-31 $-0.05B $0.73B -16.04%
2019-09-30 $-0.02B $0.26B -13.98%
2019-06-30 $-0.01B $0.26B -20.31%
2019-03-31 $-0.01B inf%
2018-12-31 $-0.01B inf%
2018-09-30 $-0.01B inf%
2018-06-30 $-0.01B inf%
2018-03-31 $-0.01B inf%
2017-12-31 $-0.00B inf%
2017-09-30 $-0.00B inf%
2017-06-30 $-0.00B inf%
2017-03-31 $0.00B inf%
2016-12-31 $0.00B inf%
2016-09-30 $0.00B 8.33%
2016-06-30 $-0.00B -2.06%
2016-03-31 $-0.01B -10.67%
2015-12-31 $-0.01B $0.10B -12.94%
2015-09-30 $-0.01B $0.10B -23.85%
2015-06-30 $-0.01B $0.11B -43.33%
2015-03-31 $-0.01B $0.01B -285.71%
2014-12-31 $-0.01B $0.01B -1040.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.248B $0.294B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $216.198B 22.61
Edwards Lifesciences (EW) United States $47.210B 32.49
Alcon (ALC) Switzerland $33.483B 28.83
STERIS (STE) Ireland $18.026B 22.43
Teleflex (TFX) United States $10.579B 17.16
Fresenius Medical Care AG KGaA (FMS) Germany $9.137B 9.17
Penumbra (PEN) United States $7.442B 1781.27
Globus Medical (GMED) United States $7.143B 36.31
Integer Holdings (ITGR) United States $2.386B 19.15
Nevro (NVRO) United States $1.572B 0.00
Paragon 28 (FNA) United States $1.556B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.248B 17.77
Artivion (AORT) United States $0.525B 0.00